Online citations, reference lists, and bibliographies.

Management Of Peritoneal-surface Malignancy: The Surgeon’s Role

Paul H Sugarbaker
Published 1999 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract Background: Peritoneal surface malignancy can result from seeding of gastrointestinal cancer or abdominopelvic sarcoma; it can also occur as a primary disease, for example, peritoneal mesothelioma. In the past, this clinical situation was treated only with palliative intent. Methods: An aggressive approach to peritoneal surface malignancy involves peritonectomy procedures, perioperative intraperitoneal chemotherapy and knowledgeable patient selection. The clinical assessments necessary for valid clinical judgements include the cancer histopathology (invasive vs expansive progression), the preoperative abdominal and pelvic computed tomogram, the peritoneal cancer index and the completeness of cytoreduction score. Proper patient selection is mandatory for optimizing the results of treatment. Results: In a series of phase-II studies, appendiceal tumors with peritoneal seeding was the paradigm for success with a 75% long-term survival in properly selected patients. Carcinomatosis from colon cancer had an overall 5-year survival of 20% but with selected patients this reached 50%. Also, sarcomatosis patients overall had only a 10% 5-year survival but selected patients had a 75% survival. In all malignancies, early aggressive treatment of minimal peritoneal surface dissemination showed the greatest benefit. Conclusions: The surgeon must accept responsibility for knowledgeable management of peritoneal surface dissemination of cancer. A curative approach has been demonstrated in large phase-II studies. Adjuvant studies with perioperative intraperitoneal chemotherapy in diseases where peritoneal surface spread occurs are indicated.
This paper references
10.1007/BF02625947
Peritoneal carcinomatosis from appendiceal cancer: A paradigm for treatment of abdomino-pelvic dissemination of gastrointestinal malignancy
Paul H Sugarbaker (2007)
10.1007/s10434-999-0790-0
Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique
Arvil D. Stephens (1999)
Recurrent intraabdominal cancer with intestinal obstruction.
Andrew M. Averbach (1995)
Peritonectomy procedures. In: Sugarbaker PH (ed) Peritoneal carcinomatosis: principles of management
PH Sugarbaker (1996)
10.1007/978-1-4613-1247-5
Peritoneal Carcinomatosis: Principles of Management
Paul H Sugarbaker (1996)
10.1002/1097-0142(197410)34:4<1278::AID-CNCR2820340440>3.0.CO;2-F
Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy.
Leonard L. Gunderson (1974)
10.1016/S0959-8049(98)00375-X
Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment.
B. Berthet (1999)
Surgical management of locally recurrent and metastatic colorectal cancer. In: Karakousis CP, Copeland EM, Bland QUI (eds) Atlas of surgical oncology
PH Sugarbaker (1995)
Management of peritoneal surface malignancy using intraperitoneal chemotherapy and cytoreductive surgery. In: A manual for physicians and nurses, 3rd edn
PH Sugarbaker (1998)
Rationale for early postoperative intraperitoneal chemotherapy (EPIC) in patients with advanced gastrointestinal cancer
PH Sugarbaker (1990)
10.1007/978-1-4613-1245-1_7
Pathobiology of peritoneal carcinomatosis from ovarian malignancy.
Tessa A. Sugarbaker (1996)
10.1007/978-1-4613-1245-1_21
Peritoneal carcinomatosis from adenocarcinoma of the colon.
Paul H Sugarbaker (1996)
10.1007/978-1-4613-1245-1
Peritoneal Carcinomatosis: Drugs and Diseases
Paul H Sugarbaker (1996)
10.1007/s002800051093
Successful management of microscopic residual disease in large bowel cancer
Paul H Sugarbaker (1999)
Peritoneal carcinomatosis from gastrointestinal malignancy: natural history and new prospects for management.
Pierre Jacquet (1994)
10.1007/978-1-4613-1247-5_17
Radiology of peritoneal carcinomatosis.
Ann G. Archer (1996)
10.1007/978-1-4613-1247-5_6
Observations concerning cancer spread within the peritoneal cavity and concepts supporting an ordered pathophysiology.
Paul H Sugarbaker (1996)
Surgery for colorectal metastasis to liver
PH Sugarbaker (1993)
Management of pseudomyxoma peritonei of appendiceal origin
PH Sugarbaker (1997)
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.
Pierre Jacquet (1995)
10.1097/00000658-199109000-00014
Second-look Surgery for Colorectal Cancer
Edward W. Jr Martin (1991)
10.1007/978-1-4613-1247-5_5
Patterns of spread of recurrent intraabdominal sarcoma.
Tessa A. Sugarbaker (1996)



This paper is referenced by
10.1097/SLA.0b013e3181e049de
Transgastric NOTES for the detection of peritoneal carcinomatosis: more targets needed for a thorough evaluation.
Yamina Ladjici (2010)
10.1245/s10434-012-2264-z
The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study
Daphne Hompes (2012)
Intraperitoneal chemotherapy for prevention and treatment of peritoneal carcinomatosis from colorectal origin
John Romanos (2003)
10.1111/1471-0528.15328
Surgery in ovarian cancer – Brazilian Society of Surgical Oncology consensus
Audrey Tieko Tsunoda (2018)
10.1155/2012/358341
Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Intraoperative Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer
Antonios-Apostolos K Tentes (2012)
10.1245/s10434-012-2651-5
A Novel Nomogram for Peritoneal Mesothelioma Predicts Survival
Nicholas P. Schaub (2012)
10.1177/030089161009600306
Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Antonios-Apostolos K Tentes (2010)
10.1007/s10151-012-0972-9
Should isolated peritoneal carcinomatosis from colorectal cancer be sub-classified into stage IVB in era of modern chemotherapy?
Hideki Ishida (2012)
Clinical and Experimental Studies in Peritoneal Metastases from Gastric Cancer
Bo Hultman (2013)
10.1245/s10434-015-4958-5
Laparoscopy is Safe and Accurate to Evaluate Peritoneal Surface Metastasis Prior to Cytoreductive Surgery
Rebecca A. Marmor (2015)
10.1002/jso.25087
Evaluation of the peritoneal surface disease severity score (PSDSS) in ovarian cancer patients undergoing cytoreductive surgery and HIPEC: Two pathogenetic types based study
Roman Yarema (2018)
10.1016/j.ctrv.2011.10.006
Diffuse malignant peritoneal mesothelioma--an update on treatment.
Peyman Mirarabshahii (2012)
10.1007/s12262-019-02017-9
Prospective Comparative Analysis of Total Versus Involved Field Parietal Peritonectomy During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) for Peritoneal Surface Malignancies from Colorectal Cancer
S. Somashekhar (2020)
10.1016/S0009-739X(08)72622-8
Open vacuum-pack, técnica ideal del cierre abdominal temporal diferido en las complicaciones tras cirugía citorreductora y quimioterapia intraperitoneal con hipertermia por carcinomatosis peritoneal
Alberto Gómez Portilla (2008)
10.1007/s12094-019-02052-8
Laparoscopic cytoreductive surgery and HIPEC is effective regarding peritoneum tissue paclitaxel distribution
D. Padilla-Valverde (2019)
10.1016/j.ejso.2015.11.011
The presence of cardiophrenic angle lymph nodes is not an indicator of peritoneal carcinomatosis from colorectal cancer on MDCT: Results of a case-control study.
Maxime Barat (2016)
10.1245/s10434-015-4989-y
Importance of Absent Neoplastic Epithelium in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Malin Enblad (2015)
10.1007/978-88-470-5711-1_5
Classification of Intraperitoneal Spread
Simone Giacopuzzi (2015)
[Management of bowel obstruction in advanced abdominal or pelvic cancer].
Bernard Denis (2002)
10.1016/S0399-8320(04)94983-4
Prise en charge symptomatique de la carcinose péritonéale
Bernard Denis (2004)
10.1111/1754-9485.12456
Proposed radiological criteria for pre-operative determination of resectability in peritoneal-based malignancies.
Grace Hwei Ching Tan (2016)
10.1245/s10434-014-4184-6
Prognostic Significance of the Lymph Node Ratio in Stage IV Colorectal Cancer Patients who have Undergone Curative Resection
Tsuyoshi Ozawa (2014)
10.1016/j.jviscsurg.2015.06.003
Pitfalls and mimickers on (18)F-FDG-PET/CT in peritoneal carcinomatosis from colorectal cancer: An analysis from 37 patients.
Raphaëlle Audollent (2015)
10.5772/26816
Combined Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for the Treatment of Advanced Ovarian Cancer
Antonios-Apostolos K Tentes (2012)
10.1080/02656736.2017.1387939
Exploring the trend in referrals for consideration of CRS and HIPEC to understand the attitudes of clinicians in the development of a national cancer centre programme in peritoneal disease
Weining Wang (2018)
10.1097/IGC.0b013e31824d836c
Evaluation of Extensive Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Epithelial Ovarian Cancer
Luca Ansaloni (2012)
10.1002/jso.24406
The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.
Richard L. Sleightholm (2016)
10.1016/j.ijscr.2019.08.024
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a patient with peritoneal carcinomatosis from a pancreatic cystadenocarcinoma: A case report
Sophia Lin (2019)
10.4251/wjgo.v2.i2.98
Peritoneal carcinomatosis of colorectal origin.
Antonio Macrì (2010)
10.1245/s10434-013-2874-0
A Phase I Trial of Thermal Sensitization Using Induced Oxidative Stress in the Context of HIPEC
Lawrence E. Harrison (2013)
10.1111/codi.14310
Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme
Rebecca Fish (2018)
Occlusion intestinale et cancer abdomino-pelvien évolué
Bernard Denis (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar